Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center

Lukasz Kwapisz; Laura E. Raffals; David H. Bruining; Darrell S. Pardi; William J. Tremaine; Sunanda V. Kane; Konstantinos A. Papadakis; Nayantara Coelho-Prabhu; John B. Kisiel; Valerie Heron; William A. Faubion; Edward V. Loftus

doi:10.1016/j.cgh.2020.02.017

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center

Lukasz Kwapisz, Laura E. Raffals, David H. Bruining, Darrell S. Pardi, William J. Tremaine, Sunanda V. Kane, Konstantinos A. Papadakis, Nayantara Coelho-Prabhu, John B. Kisiel, Valerie Heron, William A. Faubion, Edward V. Loftus

Research output: Contribution to journal › Short survey › peer-review

9 Scopus citations

Abstract

The global incidence of inflammatory bowel disease (IBD) has increased considerably during the past few decades.¹ IBDs, composed of Crohn's disease (CD) and ulcerative colitis (UC), are characterized by heterogeneous presentation and widely variable clinical course. The therapeutic goals are to induce and maintain remission. Despite the current treatments available, many patients do not achieve this goal.

Original language	English (US)
Pages (from-to)	616-617
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1016/j.cgh.2020.02.017
State	Published - Mar 2021

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1016/j.cgh.2020.02.017

Cite this

Kwapisz, L., Raffals, L. E., Bruining, D. H., Pardi, D. S., Tremaine, W. J., Kane, S. V., Papadakis, K. A., Coelho-Prabhu, N., Kisiel, J. B., Heron, V., Faubion, W. A., & Loftus, E. V. (2021). Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center. Clinical Gastroenterology and Hepatology, 19(3), 616-617. https://doi.org/10.1016/j.cgh.2020.02.017

Kwapisz, L, Raffals, LE, Bruining, DH, Pardi, DS, Tremaine, WJ, Kane, SV, Papadakis, KA, Coelho-Prabhu, N, Kisiel, JB, Heron, V, Faubion, WA & Loftus, EV 2021, 'Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center', Clinical Gastroenterology and Hepatology, vol. 19, no. 3, pp. 616-617. https://doi.org/10.1016/j.cgh.2020.02.017

@article{7e86d18a4bf34ac7ba121d12b3065645,

title = "Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center",

abstract = "The global incidence of inflammatory bowel disease (IBD) has increased considerably during the past few decades.1 IBDs, composed of Crohn's disease (CD) and ulcerative colitis (UC), are characterized by heterogeneous presentation and widely variable clinical course. The therapeutic goals are to induce and maintain remission. Despite the current treatments available, many patients do not achieve this goal.",

author = "Lukasz Kwapisz and Raffals, {Laura E.} and Bruining, {David H.} and Pardi, {Darrell S.} and Tremaine, {William J.} and Kane, {Sunanda V.} and Papadakis, {Konstantinos A.} and Nayantara Coelho-Prabhu and Kisiel, {John B.} and Valerie Heron and Faubion, {William A.} and Loftus, {Edward V.}",

note = "Publisher Copyright: {\textcopyright} 2021 AGA Institute",

year = "2021",

month = mar,

doi = "10.1016/j.cgh.2020.02.017",

language = "English (US)",

volume = "19",

pages = "616--617",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Combination Biologic Therapy in Inflammatory Bowel Disease

T2 - Experience From a Tertiary Care Center

AU - Kwapisz, Lukasz

AU - Raffals, Laura E.

AU - Bruining, David H.

AU - Pardi, Darrell S.

AU - Tremaine, William J.

AU - Kane, Sunanda V.

AU - Papadakis, Konstantinos A.

AU - Coelho-Prabhu, Nayantara

AU - Kisiel, John B.

AU - Heron, Valerie

AU - Faubion, William A.

AU - Loftus, Edward V.

PY - 2021/3

Y1 - 2021/3

N2 - The global incidence of inflammatory bowel disease (IBD) has increased considerably during the past few decades.1 IBDs, composed of Crohn's disease (CD) and ulcerative colitis (UC), are characterized by heterogeneous presentation and widely variable clinical course. The therapeutic goals are to induce and maintain remission. Despite the current treatments available, many patients do not achieve this goal.

AB - The global incidence of inflammatory bowel disease (IBD) has increased considerably during the past few decades.1 IBDs, composed of Crohn's disease (CD) and ulcerative colitis (UC), are characterized by heterogeneous presentation and widely variable clinical course. The therapeutic goals are to induce and maintain remission. Despite the current treatments available, many patients do not achieve this goal.

UR - http://www.scopus.com/inward/record.url?scp=85099282436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099282436&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2020.02.017

DO - 10.1016/j.cgh.2020.02.017

M3 - Short survey

C2 - 32068149

AN - SCOPUS:85099282436

SN - 1542-3565

VL - 19

SP - 616

EP - 617

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 3

ER -

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this